GlaxoSmithKline’s Pharmaceuticals business has been at the forefront of serving the healthcare needs of India for more than 90 years.


We have consolidated our leadership in the therapy areas where we provide healthcare solutions to patients, with a wide range of prescription medicines across areas covering anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease and respiratory diseases.



Our Marketplace

In a vast global market for pharmaceuticals, the Asia Pacific regions has seen the biggest growth over recent years and the Indian pharmaceuticals market is spearheading this growth. This trend is expected to continue as the world’s population grows, economies in the emerging markets become more prosperous and global changes in lifestyles affect long-term health.

Demand for quality healthcare has also been driven by the growing health insurance sector, which has in turn strengthened demand for quality in healthcare solutions.

Our Strategy

With opportunities in India opening up, GSK India is aligning itself with the parent company in areas such as clinical trials, clinical data management, global pack management, sourcing raw material and support for business processes including analytics. 

Quality & Manufacturing

Our manufacturing unit is located at Nashik, and our clinical development centre is in Bangalore.

Our Nashik site has embarked on deploying the GSK Production System (GPS) in line with Global Manufacturing and Supply initiatives to achieve Zero Accidents, Zero Defects & Zero Waste. To meet the growing demand for quality medicines in India, GSK is investing around INR 1000 crores in a new ‘state of the art’ pharmaceutical factory in Vemgal, near Bengaluru.

Research & Collaborations

At GSK India we are committed to Research and Development of medicines that will improve the quality of life of people and truly make a difference to patients. Our R&D unit - Pharmaceutical Research & Development (PR&D) - is approved by Department of Science and Industrial Research, Government of India.

Valuing the importance of partnerships in research, GSK currently has research collaborations with more than 3,000 external organisations worldwide and this number is growing every year. In India, PR&D has access to various research databases used globally and to latest technologies developed by GSK. Our Medical Affairs team plays a crucial role in communicating advanced scientific information with the medical fraternity.